BRPI0808333A2 - extrato bacteriano para doenças respiratórias e processo para sua preparação - Google Patents

extrato bacteriano para doenças respiratórias e processo para sua preparação

Info

Publication number
BRPI0808333A2
BRPI0808333A2 BRPI0808333A BRPI0808333A BRPI0808333A2 BR PI0808333 A2 BRPI0808333 A2 BR PI0808333A2 BR PI0808333 A BRPI0808333 A BR PI0808333A BR PI0808333 A BRPI0808333 A BR PI0808333A BR PI0808333 A2 BRPI0808333 A2 BR PI0808333A2
Authority
BR
Brazil
Prior art keywords
preparation
respiratory diseases
bacterial extract
bacterial
extract
Prior art date
Application number
BRPI0808333A
Other languages
English (en)
Inventor
Chiavaroli Carlo
Alain Bauer Jacques
Leon Vigroux Jean-Pierre
Chalvet Laetitia
Salvagni Marco
Original Assignee
Om Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Pharma filed Critical Om Pharma
Publication of BRPI0808333A2 publication Critical patent/BRPI0808333A2/pt
Publication of BRPI0808333B1 publication Critical patent/BRPI0808333B1/pt
Publication of BRPI0808333B8 publication Critical patent/BRPI0808333B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P39/00—Processes involving microorganisms of different genera in the same process, simultaneously
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
BRPI0808333A 2007-03-05 2008-03-05 extrato bacteriano para doenças respiratórias e processo para sua preparação BRPI0808333B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90478907P 2007-03-05 2007-03-05
US60/904,789 2007-03-05
PCT/US2008/055906 WO2008109669A2 (en) 2007-03-05 2008-03-05 Bacterial extract for respiratory disorders and proces for its preparation

Publications (3)

Publication Number Publication Date
BRPI0808333A2 true BRPI0808333A2 (pt) 2017-05-30
BRPI0808333B1 BRPI0808333B1 (pt) 2020-03-10
BRPI0808333B8 BRPI0808333B8 (pt) 2021-05-25

Family

ID=39739087

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0808333A BRPI0808333B8 (pt) 2007-03-05 2008-03-05 extrato bacteriano para doenças respiratórias e processo para sua preparação

Country Status (21)

Country Link
US (2) US8697154B2 (pt)
EP (2) EP3332791A1 (pt)
JP (1) JP5693010B2 (pt)
KR (1) KR101527483B1 (pt)
CN (1) CN101663041B (pt)
AR (2) AR070307A1 (pt)
AU (1) AU2008222865B2 (pt)
BR (1) BRPI0808333B8 (pt)
CA (1) CA2679843C (pt)
DK (1) DK2114421T3 (pt)
ES (1) ES2665002T3 (pt)
HU (1) HUE038598T2 (pt)
IL (1) IL200666A (pt)
MX (1) MX2009009452A (pt)
PL (1) PL2114421T3 (pt)
PT (1) PT2114421T (pt)
RU (1) RU2456007C2 (pt)
SI (1) SI2114421T1 (pt)
TW (1) TWI434693B (pt)
WO (1) WO2008109669A2 (pt)
ZA (1) ZA200906029B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401876D0 (sv) * 2004-07-16 2004-07-16 Forskarpatent I Syd Ab Prevention of allergy in children
GB2477752A (en) * 2010-02-11 2011-08-17 Arab Biotechnology Company Detection of bacteria
FR2969657B1 (fr) * 2010-12-22 2014-02-07 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie
FR2969658B1 (fr) * 2010-12-22 2014-10-17 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation therapeutique
CN103157108B (zh) * 2011-12-13 2016-01-20 宁云山 免疫调节剂组合物及其药物组合物和应用
AU2013217771A1 (en) * 2012-02-08 2014-08-28 Premune Ab Prevention of inflammatory disorders in domestic non-human mammals
BR112015021931A8 (pt) * 2013-03-11 2018-01-23 Univ Florida usos de composições farmacêuticas para prevenção e/ou tratamento de complicações do pulmão induzidas por radiação e da função pulmonar
CN105779326A (zh) * 2014-12-25 2016-07-20 河南科技学院 化脓性链球菌细胞壁成分萃取方法
CN106310246A (zh) * 2016-08-31 2017-01-11 廖正芳 一种可吸入制剂及其制备方法
KR102134385B1 (ko) 2017-02-06 2020-07-16 주식회사 한국인삼공사 홍삼 추출물을 함유하는 호흡기 증상 개선용 조성물
US9795579B1 (en) * 2017-04-24 2017-10-24 Knoze Jr. Corporation Oral microbiota promoting method
CU20210077A7 (es) 2019-03-14 2022-04-07 Om Pharma Sa Extractos bacterianos estables como fármacos
CN113613665A (zh) * 2019-03-14 2021-11-05 Om药物公司 治疗和/或预防哮喘、哮喘恶化、过敏性哮喘和/或与呼吸系统病症相关的微生物群相关的病症的方法
KR102437436B1 (ko) * 2019-04-26 2022-08-30 주식회사 엠디헬스케어 스트렙토코커스 파이오제네스 세균 유래 단백질 및 이의 용도
EP3960191A4 (en) * 2019-04-26 2023-01-04 MD Healthcare Inc. PROTEIN DERIVED FROM STREPTOCOCCUS PYOGENES BACTERIA AND ITS USE

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3532790A (en) * 1968-02-23 1970-10-06 Canadian Patents Dev Somatic antigen vaccines from lysed inactivated bacteria and process for producing them
CH633188A5 (fr) 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.
IT1199301B (it) 1986-11-21 1988-12-30 Belfanti Ist Sieroterap Milan Lisato antigenico batterico,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
CH685498A5 (fr) * 1992-02-14 1995-07-31 Om Lab Sa Extrait de macromolécules bactériennes, procédé pour sa préparation et composition pharmaceutique contenant cet extrait.
US5314822A (en) * 1992-10-15 1994-05-24 Merck & Co., Inc. Method of clonal growth of Streptococcus pneumoniae
GB9224584D0 (en) * 1992-11-23 1993-01-13 Connaught Lab Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
DK0729473T3 (da) 1993-11-17 2000-10-30 Deutsche Om Arzneimittel Gmbh Glucosamin-disaccharider, fremgangsmåde til deres fremstilling farmaceutisk sammensætning deraf og deres anvendelse
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
DE69842010D1 (de) 1997-05-28 2010-12-30 Novartis Vaccines & Diagnostic Verfahren zur Herstellung eines immunogenen Faktors von Corynebacterium diphtheriae unter Verwendung eines Kulturmediums mit Hefeextrakt als Aminosäurenquelle und ohne Proteinkomplexe tierischer Herkunft
US20040087020A1 (en) * 1997-05-28 2004-05-06 Chiron S.P.A. Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
US20010051364A1 (en) * 1997-12-23 2001-12-13 Francis Michon Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines
DE69841676D1 (de) * 1997-12-23 2010-07-01 Baxter Healthcare Sa Verfahren zur extraktion und isolierung von bakteriellen hüllpolysacchariden zur verwendung als vakzine oder, an proteine gekoppelt, als konjugierte vakzine
JP2000319294A (ja) * 1999-05-11 2000-11-21 Asahi Chem Ind Co Ltd 生物由来高分子溶液精製方法
FR2822071B1 (fr) 2001-03-15 2005-07-01 Pf Medicament Utilisation d'une fraction membranaire de bacteries a gram negatif pour induire la maturation des cellules dendritiques
CA2530364C (en) * 2003-06-23 2014-03-18 Baxter International Inc. Vaccines against group y neisseria meningitidis and meningococcal combinations thereof
EP1656025A4 (en) 2003-08-18 2007-12-05 Bio Balance Corp STABLE LIQUID PROBIOTIC COMPOSITION, PREPARATION AND CORRESPONDING APPLICATIONS
US7354740B2 (en) * 2003-09-25 2008-04-08 Allergan, Inc. Animal product free system and process for purifying a botulinum toxin
EP1848448B8 (en) 2005-02-08 2010-09-15 Parmeggiani, Francesco Use of a lyophilised bacterial lysate for the prevention of tuberculosis relapse
KR20070122458A (ko) * 2005-02-11 2007-12-31 에이스 바이오사이언시즈 에이/에스 표재성 스트렙토코커스 뉴모니아 폴리펩티드
WO2006095431A1 (ja) * 2005-03-10 2006-09-14 Kyoritsu Seiyaku Corporation 動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法
EP1976857A4 (en) 2006-01-13 2011-08-03 Baxter Int PROCESS FOR CLEANING POLYSACCHARIDES
JP6041458B2 (ja) * 2007-03-05 2016-12-07 オーエム ファーマＯｍ Ｐｈａｒｍａ 消化管又は尿管の障害のための細菌抽出物及びその製造方法

Also Published As

Publication number Publication date
AR111836A2 (es) 2019-08-21
IL200666A0 (en) 2010-05-17
JP2010520302A (ja) 2010-06-10
IL200666A (en) 2016-12-29
RU2009136577A (ru) 2011-04-10
BRPI0808333B1 (pt) 2020-03-10
TWI434693B (zh) 2014-04-21
KR20090122940A (ko) 2009-12-01
EP2114421A4 (en) 2010-09-22
TW200938212A (en) 2009-09-16
AU2008222865A1 (en) 2008-09-12
ES2665002T3 (es) 2018-04-24
CN101663041A (zh) 2010-03-03
BRPI0808333B8 (pt) 2021-05-25
WO2008109669A3 (en) 2008-12-18
CA2679843C (en) 2018-10-02
KR101527483B1 (ko) 2015-06-09
EP2114421A2 (en) 2009-11-11
US20140205693A1 (en) 2014-07-24
CA2679843A1 (en) 2008-09-12
ZA200906029B (en) 2010-11-24
RU2456007C2 (ru) 2012-07-20
WO2008109669A2 (en) 2008-09-12
PL2114421T3 (pl) 2018-07-31
DK2114421T3 (en) 2018-04-23
PT2114421T (pt) 2018-04-17
HUE038598T2 (hu) 2018-10-29
EP2114421B1 (en) 2018-01-10
EP3332791A1 (en) 2018-06-13
MX2009009452A (es) 2009-09-14
CN101663041B (zh) 2012-05-23
SI2114421T1 (en) 2018-04-30
US20100227013A1 (en) 2010-09-09
AR070307A1 (es) 2010-03-31
US8697154B2 (en) 2014-04-15
US9463209B2 (en) 2016-10-11
JP5693010B2 (ja) 2015-04-01
AU2008222865B2 (en) 2013-01-31

Similar Documents

Publication Publication Date Title
BRPI0808333A2 (pt) extrato bacteriano para doenças respiratórias e processo para sua preparação
BRPI0812073A2 (pt) Laminado para moldagem de encaixe e método de sua fabricação, e moldagem de encaixe e método de sua fabricação
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI0819819A2 (pt) Preparações, método e kits ùteis para o tratamento de tosse
BRPI0913710A2 (pt) "artigo e métodos para preparação do artigo"
BRPI1009840A2 (pt) Base saborosa realçadora de sabor natural e processo para sua preparação
BRPI0819237A2 (pt) folha de material e processo para sua preparação
BRPI0816640A2 (pt) "método para produzir produtos de proteína estável ácida e produtos assim produzidos"
BRPI0716439A2 (pt) formulaÇÕes de flibanserina e mÉtodo para fabricaÇço das mesmas.
BRPI0819714A2 (pt) Formulações de proteína e métodos de produção das mesmas.
BRPI0914902A2 (pt) composição farmacêutica e método para tratamento de mal de parkinson
BRPI1012525A2 (pt) composições de nanopatículas isentas de príons e métodos para sua fabricação
BRPI0817254A2 (pt) Base saborosa intensificadora de sabor e um processo para sua preparação
BRPI0812448A2 (pt) Método para aperfeiçoamento de propriedades de proteína
BRPI0811805A2 (pt) "artigo absorvente alongado e método para sua fabricação".
BRPI0822349A2 (pt) composições e métodos para tratar doenças lisossômicas
FI20070569A0 (fi) Uusi stabiili tuote ja menetelmä sen valmistamiseksi
FR2911781B1 (fr) Emulsion dermatologique et procede de preparation
BRPI0913074A2 (pt) pneumático e método para sua fabricação
BR112012001344A2 (pt) derivados de 17hidróxi-17-pentafluoroetil-estra-4,9(10)-dieno-11-arila, método de produção destes e uso destes para o tratamento de doenças
BR112013007457A2 (pt) formulações farmacêuticas contendo rifaximina, processos para a sua obtenção e método de tratar doença intestinal
BRPI0818736A2 (pt) composições e métodos para intensificar imunorrepostas à bactéria flagelada
BRPI0909885A2 (pt) composição decorativa e método para sua utilização
BRPI0811930A2 (pt) Métodos e composições para a identificação e o tratamento de lúpus
BRPI0905790A2 (pt) 'micropartícula, método para a fabricação de micropartícula e preparação farmacêutica

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/03/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/03/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF